References
- Pitt B, Rubenfire M. Risk stratification for the detection of preclinical coronary artery disease. Circulation 1999; 99(20): 2610–2
- Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97(18): 1837–47
- Grundy SM. Primary prevention of coronary heart disease: integrating risk assessment with intervention. Circulation 1999; 100(9): 988–98
- Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486–97
- Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993, 269(23): 3015–23
- Wood D, De Backer G, Faergeman O, et al. Prevention of coronary heart disease in clinical practice: summary of recommendations of the Second Joint Task Force of European and Other Societies on Coronary Prevention. J Hypertens 1998; 16(10): 1407–14
- Roberts WC. Shifting from decreasing risk to actually preventing and arresting atherosclerosis. Am J Cardiol 1999; 83(5): 816–7
- Kannel WB. Range of serum cholesterol values in the population developing coronary artery disease. Am J Cardiol 1995; 76(9): 69–77C
- Grundy SM, Bazzarre T, Cleeman J, et al. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Medical office assessment: Writing Group I. Circulation 2000; 101 (1): E3–11
- Wilson PW, Kannel WB, Silbershatz H, et al. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999; 159(10): 1104–9
- Dormandy J, Heeck L, Vig S. Lower-extremity arteriosclerosis as a reflection of a systemic process: implications for concomitant coronary and carotid disease. Semin Vase Surg 1999; 12(2): 118–22
- Dormandy J, Heeck L, Vig S. The natural history of claudication: risk to life and limb. Semin Vase Surg 1999; 12(2): 123–37
- Violi F, Criqui M, Longoni A, et al. Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease: results from the ADEP study. Atherosclerosis 1996; 120(1–2): 25–35
- O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 2000; 102(1): 126–40
- Grundy SM. Age as a risk factor: you are as old as your arteries. Am J Cardiol 1999; 83(10): 1455–7, A7
- Grundy SM. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 1997; 95(1):1–4
- Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279(20): 1615–22
- Edmunowicz D, Andrews TC, Shear CL. Comparing treatment success with statins: results from the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS). (Abstr) J Am Coll Cardiol 2000; 35:314A
- Insull W. The problem of compliance to cholesterol altering therapy. J Intern Med 1997; 241 (4):317–25